Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Environmental and Molecular Mutagenesis|March 29, 2002
Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemopreventionJoAnne Zujewski
Clinical Breast Cancer|September 3, 2005
Sentinel lymph node biopsy in the management of ductal carcinoma in situJoAnne Zujewski, Jennifer Eng-Wong
Postgraduate Medicine|October 30, 2004
Assessing breast cancer risk: genetic factors are not the whole storyLarissa A Korde, Kathleen A Calzone, JoAnne Zujewski
Breast Cancer Research and Treatment|April 11, 2015
Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapyLindsey Enewold, Ann M Geiger, JoAnne Zujewski, et al.
The Journal of Endocrinology|December 16, 2006
Effect of raloxifene on salivary sex steroid concentrations in premenopausal womenRobert T Chatterton, JoAnne Zujewski, Esnar T Mateo, et al.
JCO Global Oncology|February 8, 2020
Patient Advocacy Approaches to Improving Care for Breast and Cervical Cancer in East and Southern AfricaDarya A Kizub, JoAnne Zujewski, Julie R Gralow, et al.
Annals of Surgical Oncology|July 4, 2003
Preoperative FLAC/granulocyte-colony-stimulating factor chemotherapy for stage II breast cancer: a prospective randomized trialDavid N Danforth, Kenneth Cowan, Rosemary Altemus, et al.
Fertility and Sterility|July 31, 2007
Gynecologic and hormonal effects of raloxifene in premenopausal womenAhalya Premkumar, David J Venzon, Nilo Avila, et al.
Breast Cancer Research and Treatment|September 24, 2002
The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancerDavid N Danforth, Luigi Aloj, Jorge A Carrasquillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancerPeter F Lebowitz, Jennifer Eng-Wong, Brigitte C Widemann, et al.
Pageof 2